News about Drug Discovery & Development

BioNTech 2nd phase of Covid 19 trials completed

BioNTech 2nd phase of Covid 19 trials completed

The vaccine, based on messenger RNA (mRNA) technology, is one of the most widely used worldwide against COVID, but has yet to receive an approval in China, which has relied only on domestically-developed vaccine

Drug Discovery & Development | 12/05/2022 | By Sudeep Soparkar

US FDA approval for Incyte's Olumiant

US FDA approval for Incyte's Olumiant

Eli Lilly and Company and Incyte announced the US Food and Drug Administration (FDA) has approved Olumiant (baricitinib) for the treatment of Covid-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) with a recommended dose of 4-mg once daily for 14 days.

Drug Discovery & Development | 12/05/2022 | By Sudeep Soparkar

The Dutch company MIMETAS expanded its license to the HUB Organoid Technology to include all organs

The Dutch company MIMETAS expanded its license to the HUB Organoid Technology to include all organs

These miniature organs are used to develop therapies against incurable diseases.

Drug Discovery & Development | 11/05/2022 | By Content editor


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology